Browse wiki

Jump to navigation Jump to search
NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues"
Show incoming properties 
Category
Generic Letter  and Unfiltered
Has query"Has query" is a predefined property that represents meta information (in form of a <a rel="nofollow" class="external text" href="https://www.semantic-mediawiki.org/wiki/Subobject">subobject</a>) about individual queries and is provided by <a rel="nofollow" class="external text" href="https://www.semantic-mediawiki.org/wiki/Help:Special_properties">Semantic MediaWiki</a>.
NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +, NRC Generic Letter 85-17, Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues" +...
Issue date
August 23, 1985  +
Modification date"Modification date" is a predefined property that corresponds to the date of the last modification of a subject and is provided by <a rel="nofollow" class="external text" href="https://www.semantic-mediawiki.org/wiki/Help:Special_properties">Semantic MediaWiki</a>.
00:26:25, 19 February 2020  +
NUREG
NUREG-1050, Forwards Regulatory Analysis of Generic Safety Issue 61, Safety/Relief Valve Discharge Line Break within Mark I or II Wetwell Airspace. Based on Results Discussed in NUREG/CR-4594,risk Lower than Previously Estimated +
Name
Availability of Supplements 2 and 3 to NUREG-0933, "A Prioritization of Generic Safety Issues"  +
State
Washington +
URL"URL" is a <a href="/Special:Types/URL" title="Special:Types/URL">type</a> and predefined property provided by <a rel="nofollow" class="external text" href="https://www.semantic-mediawiki.org/wiki/Help:Special_properties">Semantic MediaWiki</a> to represent URI/URL values.
https://www.nrc.gov/reading-rm/doc-collections/gen-comm/gen-letters/1985/gl85017.html  +
 
Retrieved from "https://kanterella.com/Special:Browse/:NRC-20Generic-20Letter-2085-2D17,-20Availability-20of-20Supplements-202-20and-203-20to-20NUREG-2D0933,-20%22A-20Prioritization-20of-20Generic-20Safety-20Issues%22"